Avalon Pharma Secures SAR60 Million Credit Facility

MT Newswires · 3d ago
01:31 AM EST, 11/09/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, obtained a 60 million-Saudi-riyal credit facility from the Saudi Industrial Development Fund. The facility has a duration of two years, with the funds to be used as working capital, the Tadawul-listed pharmaceutical company said Monday.